Across TCGA pan-cancer cohorts, LEKR1 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LEKR1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LEKR1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types LEKR1 is over-expressed in tumor.

HNSC and COAD are the cancer types where LEKR1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LEKR1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.377	<.001	8	view →
COAD	All	All	+0.739	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LEKR1 RNA expression & survival · all LEKR1 data types